CAMBRIDGE, Mass. & RESEARCH TRIANGLE PARK, N.C. & SEOUL, Korea, October 07, 2024–Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced that Shaperon and Hudson Therapeutics will participate in five major international conferences this fall. With a strategic focus on securing global licensing partnerships, Shaperon and Hudson Therapeutics will actively promote its innovative clinical programs addressing significant unmet needs in atopic dermRead More